NCT01101087

Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency

Efficacity of Taurolock in Preventing Primary Bacterial Peritonitis in Patients Undergoing Peritoneal Dialysis for Renal Insufficiency: a Randomized, Multicenter, Double Blind Study With Placebo

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Centre Hospitalier Universitaire de Nīmes · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Dialysis catheters are sites of bacterial proliferation. The purpose of this study is to determine whether or not the use of Taurolock (a catheter lock solution) can prevent bacterial peritonitis in patients undergoing peritoneal dialysis.

Conditions

• Peritonitis
• Catheter-related Infections
• Renal Insufficiency

Interventions

Type	Name	Description
DEVICE	Taurolock
OTHER	Placebo	Injectable sodium chloride conditioned in exactly the same manner as the experimental product.

Timeline

• Start date: 2010-07-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2010-04-09
• Last updated: 2015-12-18

Locations

15 sites across 2 countries: France, French Polynesia